The present study demonstrates that Hsp90ab1 is a regulator of skeletal muscle metabolism and suppression of Hsp90ab1 is a valid therapeutic clinically relevant strategy in the management of dysregulated metabolic disease and insulin resistance. The gene discussed is HSP90AB1; the disease is metabolic disease.